Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

COVID-10 GPH

COVID-19 GPH|Home|PHGKB

Heart, Lung, Blood and Sleep Disorders

Last data update: Jun 04, 2023 . (Total: 45369 Documents since 2020)
   dataset      

Filtered By:

Previous    

Records 1-30 (of 37 Records)

Next

Query Trace: Sickle Cell Disease[original query]
Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO).
Tuan Jessica J, et al. BMC infectious diseases 2023 0 0. (1) 258
type type type
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
Lundstrom Kenneth, et al. Viruses 2023 0 0. (3)
type
Cerebral fat embolism syndrome in a patient with homozygous sickle cell disease in the setting of multisystem inflammatory syndrome in children.
Sepulveda Kirstin, et al. Proceedings (Baylor University. Medical Center) 2023 0 0. (2) 266-268
type
A perspective on the sickle cell disease international COVID-19 registry.
Mucalo Lana, et al. Best practice & research. Clinical haematology 2022 0 0. (3) 101385
Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.
Joseph Laure, et al. British journal of haematology 2022 0 0.
type type
Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
Varelas Christos, et al. Hemoglobin 2022 0 0. 1-3
type type
Examining resilience of individuals living with sickle cell disease in the COVID-19 pandemic.
Buscetta Ashley J, et al. BMC psychology 2022 0 0. (1) 156
Sickle Cell Disease and COVID-19 Infection: Importance of COVID-19 Testing and Approach to Management.
Umar Zaryab, et al. Cureus 2022 0 0. (3) e23604
Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia.
Al-Ansari Rehab Y, et al. Journal of family & community medicine 2022 0 0. (1) 71-78
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
Hoogenboom Wouter S, et al. Blood reviews 2021 0 0. 100911
type type
COVID-19 and Sickle Cell Disease: Frequently Asked Questions
American Society for Hematology, 2021
How do people with sickle cell disease (SCD) do with COVID-19? How should I evaluate respiratory symptoms in children and adults with an active COVID-19 infection? Should I change my use of exchange transfusion for neurological acute symptoms suggesting a stroke or transient ischemic attack? Should I change my use of exchange transfusion or regular blood transfusion for primary and secondary stroke prevention, secondary prevention of ACS, pain or priapism? My patient usually receives antigen-matched red cells. Should I use non-matched units if there is a blood shortage?
Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.
Madany Emaan, et al. Frontiers in medicine 2021 0 0. 679030
Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease.
Mucalo Lana, et al. Blood advances 2021 0 0. (13) 2717-2724
type type
Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
Haghpanah Sezaneh, et al. Hemoglobin 2021 0 0. 1-9
type type type
[Epidemiological and clinical profile of children with Coronavirus disease (COVID-19) at the Center for the Treatment of Epidemics and Infection Prevention (CTEIP) of the University Hospital of Donka in Conakry].
Camara Emmanuel, et al. The Pan African medical journal 2021 0 0. 363
type
COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals.
Singh Ashima, et al. Blood advances 2021 4 0. (7) 1915-1921
type type type
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Rankine-Mullings Angela E, et al. The Cochrane database of systematic reviews 2021 3 0. CD003427
type
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic.
Yasara Nirmani, et al. Orphanet journal of rare diseases 2021 0 0. (1) 114
type
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
Minniti Caterina P, et al. Blood advances 2021 1 0. (1) 207-215
type type
Guideline on the peri-operative management of patients with sickle cell disease: Guideline from the Association of Anaesthetists.
Walker I, et al. Anaesthesia 2021 2 0.
type
A Machine Learning Study of 534,023 Medicare Beneficiaries with COVID-19: Implications for Personalized Risk Prediction
Dun, Chen et al. medRxiv October 30 2020
type
Clinical Spectrum of Sickle Cell Disease and COVID-19: Laboratory and Clinical Factors Associated with Morbidity and Mortality
Minniti, Caterina P et al. SSRN October 15 2020
Prognosis of patients with sickle cell disease and COVID-19: a French experience.
Arlet Jean-Benoît, et al. The Lancet. Haematology 2020 0 0. (9) e632-e634
Sickle cell trait and the potential risk of severe coronavirus disease 2019-A mini-review.
Kehinde Tawakalitu Abosede, et al. European journal of haematology 2020 0 0. (5) 519-523
type
Host genetic effects in pneumonia.
Chen Hung-Hsin, et al. American journal of human genetics 2021 0 0. (1) 194-201
type
COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation.
Farmakis Dimitrios, et al. European journal of haematology 2020 10 0. (4) 378-386
type
Hemoglobinopathy and pediatrics in the time of COVID-19.
Vilela Thiago de Souza, et al. Hematology, transfusion and cell therapy 2020 12 0.
type type
Integrating Datasets on Public Health and Clinical Aspects of Sickle Cell Disease for Effective Community-Based Research and Practice.
Isokpehi Raphael D, et al. Diseases (Basel, Switzerland) 2020 10 0. (4)
type
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
Panepinto Julie A et al. Emerging infectious diseases 2020 26(10) 2473-2476
Sickle cell disease (SCD) disproportionately affects Black or African American persons in the United States and can cause multisystem organ damage and reduced lifespan. Among 178 persons with SCD in the United States who were reported to an SCD–coronavirus disease case registry, 122 (69%) were hospitalized and 13 (7%) died.
COVID-19 and sickle cell disease in Bahrain.
AbdulRahman Abdulkarim, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 9 0.
type
Next
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
TOP